Atrial fibrillation burden should be the primary outcome in rhythm control trials - discussion

26 August 2023 (09:45 - 10:00)

Organised by:

Video

Sign in for access options

5 More presentations in this session

Presentation thumbnail

Early rhythm control is best for all patients with atrial fibrillation: pro

Doctor J. Andrade (Vancouver, CA)

Presentation thumbnail

Early rhythm control is best for all patients with atrial fibrillation: con

Professor T. Potpara (Belgrade, RS)

Presentation thumbnail

Early rhythm control is best for all patients with atrial fibrillation - discussion

Presentation thumbnail

Atrial fibrillation burden should be the primary outcome in rhythm control trials: pro

Professor C. Sticherling (Basel, CH)

Presentation thumbnail

Atrial fibrillation burden should be the primary outcome in rhythm control trials: con

Professor A. Goette (Paderborn, DE)

Access the full session

Session thumbnail

Great Debate: controversies in atrial fibrillation - early rhythm control and atrial fibrillation burden

The Event

Event poster

ESC Congress 2023

26 August 2023 09:45 CET

You may be interested in

Congress Presentation

AF burden and its clinical implication

16 April 2023

Congress Presentation

First-line atrial fibrillation ablation should be offered to all patients with atrial fibrillation and heart failure with reduced ejection fraction (HFrEF) - discussion

27 August 2023

Congress Session

Late-Breaking Clinical Science: stroke prevention

1 September 2025

Congress Session

Atrial fibrillation progression and atrial fibrillation burden: do they matter?

25 August 2023

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources